This session will review appropriate clinical indications for cardiac biomarker testing, strategies to avoid unnecessary biomarkers testing and effective quality improvement interventions to reduce unnecessary biomarker testing among hospitalized patients.
This session is presented by Christine Soong, MD, MSc and David Berg, MD, MPH. Our moderators are Lily Ackermann, MD, ScM, FHM and Ebrahim Barkoudah, MD, FACP, MPH, SFHM.